Compare TWST & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TWST | SNEX |
|---|---|---|
| Founded | 2013 | 1924 |
| Country | United States | United States |
| Employees | N/A | 5400 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 6.8B |
| IPO Year | 2018 | 1996 |
| Metric | TWST | SNEX |
|---|---|---|
| Price | $110.22 | $54.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 3 |
| Target Price | $128.92 | ★ $133.28 |
| AVG Volume (30 Days) | ★ 2.3M | 775.9K |
| Earning Date | 11-12-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.49 |
| Revenue | $459,433,000.00 | ★ $132,378,200,000.00 |
| Revenue This Year | $21.02 | N/A |
| Revenue Next Year | $18.75 | N/A |
| P/E Ratio | ★ N/A | $16.27 |
| Revenue Growth | 22.00 | ★ 32.53 |
| 52 Week Low | $25.23 | $52.26 |
| 52 Week High | $219.71 | $141.99 |
| Indicator | TWST | SNEX |
|---|---|---|
| Relative Strength Index (RSI) | 38.28 | 40.52 |
| Support Level | $79.90 | $52.26 |
| Resistance Level | $155.44 | $71.09 |
| Average True Range (ATR) | 15.07 | 1.97 |
| MACD | -3.22 | 0.49 |
| Stochastic Oscillator | 18.52 | 41.99 |
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
StoneX Group Inc is a brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.